US8809307 — Pharmaceutical formulations containing corticosteroids for topical administration
Formulation · Assigned to Dow Pharmaceutical Sciences Inc · Expires 2031-11-02 · 5y remaining
What this patent protects
This patent protects pharmaceutical formulations containing corticosteroids for topical administration that maintain potency even with reduced corticosteroid concentration.
USPTO Abstract
The potency of a topical corticosteroid in a pharmaceutical formulation is maintained even when the concentration of the corticosteroid is substantially reduced by providing the corticosteroid in a formulation containing a liquid oil component that includes a dicarboxylic acid ester and/or a monocarboxylic acid ester.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.